Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-03-02 @ 4:05 AM
Study NCT ID:
NCT02775435
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2016-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-15
First Submit QC Date:
None
Study First Post Date:
2016-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-19
Results First Submit QC Date:
None
Results First Post Date:
2019-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL